As of today, Phase 1 and preclinical data showed positive results, and Dr.Fauci is optimistic. There is a high likelihood that he is talking about Inovio Pharmaceuticals. Inovio Pharmaceuticals will only publish data through a peer-reviewed journal. This may take more time but show a strong level of evidence and objectivity compared to Moderna disclosing incomplete data prematurely. Additional funding from CEPI, BARDA funding may come after phase 1 data has been published and DOD may sign an additional contract to expedite INO-4800 manufacturing.
Market Data 
Markets 
AI
